Can treatment with Seraph 100 benefit COVID-19 patients?

Seraph 100 binds SARS-CoV-2. Clinicians reported that during and after treatment, inflammatory markers (such as IL-6, d-dimer, and ferritin) were reduced, as well as blood pressure stabilization and a reduced demand for vasopressors.

Seraph 100 has a wide range of applications and can safely reduce drug-susceptible and drug-resistant pathogens in the blood. Secondary bacterial or fungal infections from other sources are known complications of COVID-19.

Overview on Seraph 100 & COVID-19